Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Dec 15;88(24):11460–11464. doi: 10.1073/pnas.88.24.11460

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

D Papahadjopoulos 1, T M Allen 1, A Gabizon 1, E Mayhew 1, K Matthay 1, S K Huang 1, K D Lee 1, M C Woodle 1, D D Lasic 1, C Redemann 1, et al.
PMCID: PMC53155  PMID: 1763060

Abstract

The results obtained in this study establish that liposome formulations incorporating a synthetic polyethylene glycol-derivatized phospholipid have a pronounced effect on liposome tissue distribution and can produce a large increase in the pharmacological efficacy of encapsulated antitumor drugs. This effect is substantially greater than that observed previously with conventional liposomes and is associated with a more than 5-fold prolongation of liposome circulation time in blood, a marked decrease in uptake by tissues such as liver and spleen, and a corresponding increased accumulation in implanted tumors. These and other properties described here have expanded considerably the prospects of liposomes as an effective carrier system for a variety of pharmacologically active macromolecules.

Full text

PDF
11460

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abra R. M., Hunt C. A. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta. 1981 Dec 23;666(3):493–503. doi: 10.1016/0005-2760(81)90311-8. [DOI] [PubMed] [Google Scholar]
  2. Allen T. M., Austin G. A., Chonn A., Lin L., Lee K. C. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta. 1991 Jan 9;1061(1):56–64. doi: 10.1016/0005-2736(91)90268-d. [DOI] [PubMed] [Google Scholar]
  3. Allen T. M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987 Oct 19;223(1):42–46. doi: 10.1016/0014-5793(87)80506-9. [DOI] [PubMed] [Google Scholar]
  4. Allen T. M., Everest J. M. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J Pharmacol Exp Ther. 1983 Aug;226(2):539–544. [PubMed] [Google Scholar]
  5. Allen T. M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta. 1991 Jul 1;1066(1):29–36. doi: 10.1016/0005-2736(91)90246-5. [DOI] [PubMed] [Google Scholar]
  6. Allen T. M., Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta. 1991 Sep 30;1068(2):133–141. doi: 10.1016/0005-2736(91)90201-i. [DOI] [PubMed] [Google Scholar]
  7. Allen T. M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta. 1989 May 19;981(1):27–35. doi: 10.1016/0005-2736(89)90078-3. [DOI] [PubMed] [Google Scholar]
  8. Allen T. M., Mehra T. Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake into the reticuloendothelial system. Proc West Pharmacol Soc. 1989;32:111–114. [PubMed] [Google Scholar]
  9. Allen T. M., Williamson P., Schlegel R. A. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8067–8071. doi: 10.1073/pnas.85.21.8067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Alving C. R., Richards R. L. Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol Lett. 1990 Aug;25(1-3):275–279. doi: 10.1016/0165-2478(90)90127-c. [DOI] [PubMed] [Google Scholar]
  11. Bally M. B., Nayar R., Masin D., Hope M. J., Cullis P. R., Mayer L. D. Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta. 1990 Mar 30;1023(1):133–139. doi: 10.1016/0005-2736(90)90018-j. [DOI] [PubMed] [Google Scholar]
  12. Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta. 1990 Nov 2;1029(1):91–97. doi: 10.1016/0005-2736(90)90440-y. [DOI] [PubMed] [Google Scholar]
  13. Derksen J. T., Morselt H. W., Scherphof G. L. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim Biophys Acta. 1988 Sep 16;971(2):127–136. doi: 10.1016/0167-4889(88)90184-x. [DOI] [PubMed] [Google Scholar]
  14. Düzgüneş N., Wilschut J., Hong K., Fraley R., Perry C., Friend D. S., James T. L., Papahadjopoulos D. Physicochemical characterization of large unilamellar phospholipid vesicles prepared by reverse-phase evaporation. Biochim Biophys Acta. 1983 Jul 13;732(1):289–299. doi: 10.1016/0005-2736(83)90214-6. [DOI] [PubMed] [Google Scholar]
  15. Forssen E. A., Tökes Z. A. In vitro and in vivo studies with adriamycin liposomes. Biochem Biophys Res Commun. 1979 Dec 28;91(4):1295–1301. doi: 10.1016/0006-291x(79)91207-5. [DOI] [PubMed] [Google Scholar]
  16. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949–6953. doi: 10.1073/pnas.85.18.6949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gabizon A., Peretz T., Sulkes A., Amselem S., Ben-Yosef R., Ben-Baruch N., Catane R., Biran S., Barenholz Y. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1795–1803. doi: 10.1016/0277-5379(89)90350-7. [DOI] [PubMed] [Google Scholar]
  18. Gabizon A., Price D. C., Huberty J., Bresalier R. S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res. 1990 Oct 1;50(19):6371–6378. [PubMed] [Google Scholar]
  19. Gabizon A., Shiota R., Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst. 1989 Oct 4;81(19):1484–1488. doi: 10.1093/jnci/81.19.1484. [DOI] [PubMed] [Google Scholar]
  20. Gabizon A., Trainin N. Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br J Cancer. 1980 Oct;42(4):551–558. doi: 10.1038/bjc.1980.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hong K., Friend D. S., Glabe C. G., Papahadjopoulos D. Liposomes containing colloidal gold are a useful probe of liposome-cell interactions. Biochim Biophys Acta. 1983 Jul 13;732(1):320–323. doi: 10.1016/0005-2736(83)90220-1. [DOI] [PubMed] [Google Scholar]
  22. Huang S. K., Hong K., Lee K. D., Papahadjopoulos D., Friend D. S. Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues. Biochim Biophys Acta. 1991 Oct 14;1069(1):117–121. doi: 10.1016/0005-2736(91)90111-k. [DOI] [PubMed] [Google Scholar]
  23. Hwang K. J., Luk K. F., Beaumier P. L. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4030–4034. doi: 10.1073/pnas.77.7.4030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jain R. K., Gerlowski L. E. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol. 1986;5(2):115–170. doi: 10.1016/s1040-8428(86)80023-3. [DOI] [PubMed] [Google Scholar]
  25. Jain R. K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6(4):559–593. doi: 10.1007/BF00047468. [DOI] [PubMed] [Google Scholar]
  26. Juliano R. L., Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun. 1975 Apr 7;63(3):651–658. doi: 10.1016/s0006-291x(75)80433-5. [DOI] [PubMed] [Google Scholar]
  27. Klibanov A. L., Maruyama K., Torchilin V. P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990 Jul 30;268(1):235–237. doi: 10.1016/0014-5793(90)81016-h. [DOI] [PubMed] [Google Scholar]
  28. Lasic D. D., Martin F. J., Gabizon A., Huang S. K., Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta. 1991 Nov 18;1070(1):187–192. doi: 10.1016/0005-2736(91)90162-2. [DOI] [PubMed] [Google Scholar]
  29. Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M. P., Keating M., Rosenblum M. G., Mehta R., Luna M., Hersh E. M. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985 Apr;151(4):704–710. doi: 10.1093/infdis/151.4.704. [DOI] [PubMed] [Google Scholar]
  30. Mauk M. R., Gamble R. C. Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study. Proc Natl Acad Sci U S A. 1979 Feb;76(2):765–769. doi: 10.1073/pnas.76.2.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mayhew E. G., Goldrosen M. H., Vaage J., Rustum Y. M. Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. J Natl Cancer Inst. 1987 Apr;78(4):707–713. [PubMed] [Google Scholar]
  32. Olson F., Hunt C. A., Szoka F. C., Vail W. J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta. 1979 Oct 19;557(1):9–23. doi: 10.1016/0005-2736(79)90085-3. [DOI] [PubMed] [Google Scholar]
  33. Olson F., Mayhew E., Maslow D., Rustum Y., Szoka F. Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol. 1982 Feb;18(2):167–176. doi: 10.1016/0277-5379(82)90060-8. [DOI] [PubMed] [Google Scholar]
  34. Papahadjopoulos D., Gabizon A. Targeting of liposomes to tumor cells in vivo. Ann N Y Acad Sci. 1987;507:64–74. doi: 10.1111/j.1749-6632.1987.tb45792.x. [DOI] [PubMed] [Google Scholar]
  35. Presant C. A., Proffitt R. T., Turner A. F., Williams L. E., Winsor D., Werner J. L., Kennedy P., Wiseman C., Gala K., McKenna R. J. Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer. 1988 Sep 1;62(5):905–911. doi: 10.1002/1097-0142(19880901)62:5<905::aid-cncr2820620509>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  36. Proffitt R. T., Williams L. E., Presant C. A., Tin G. W., Uliana J. A., Gamble R. C., Baldeschwieler J. D. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science. 1983 Apr 29;220(4596):502–505. doi: 10.1126/science.6836294. [DOI] [PubMed] [Google Scholar]
  37. Rahman A., Kessler A., More N., Sikic B., Rowden G., Woolley P., Schein P. S. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 1980 May;40(5):1532–1537. [PubMed] [Google Scholar]
  38. Sculier J. P., Coune A., Meunier F., Brassinne C., Laduron C., Hollaert C., Collette N., Heymans C., Klastersky J. Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol. 1988 Mar;24(3):527–538. doi: 10.1016/s0277-5379(98)90033-5. [DOI] [PubMed] [Google Scholar]
  39. Senior J., Crawley J. C., Gregoriadis G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta. 1985 Mar 29;839(1):1–8. doi: 10.1016/0304-4165(85)90174-6. [DOI] [PubMed] [Google Scholar]
  40. Senior J., Gregoriadis G. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci. 1982 Jun 14;30(24):2123–2136. doi: 10.1016/0024-3205(82)90455-6. [DOI] [PubMed] [Google Scholar]
  41. Sommerman E. F., Pritchard P. H., Cullis P. R. 125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo. Biochem Biophys Res Commun. 1984 Jul 18;122(1):319–324. doi: 10.1016/0006-291x(84)90477-7. [DOI] [PubMed] [Google Scholar]
  42. Storm G., van Bloois L., Brouwer M., Crommelin D. J. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta. 1985 Sep 10;818(3):343–351. doi: 10.1016/0005-2736(85)90008-2. [DOI] [PubMed] [Google Scholar]
  43. Treat J., Greenspan A., Forst D., Sanchez J. A., Ferrans V. J., Potkul L. A., Woolley P. V., Rahman A. Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J Natl Cancer Inst. 1990 Nov 7;82(21):1706–1710. doi: 10.1093/jnci/82.21.1706. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES